Cough & Cold Medicine Manufacturing OTC in the US - Industry Market Research Report
Description
Cough & Cold Medicine Manufacturing OTC in the US
Companies in the Cough and Cold Medicine Manufacturing OTC industry have benefited from increasing consumers purchasing over-the-counter (OTC) medications to address ailments with at-home treatments. The COVID-19 pandemic has been the most prominent proponent for industry demand. In 2020 industry revenue increased as consumers stockpiled industry products to address symptoms and potential infection with the fear of a new COVID-19 variant. Overall, industry-wide revenue has been growing at a CAGR of 5.6% over the past five years and is expected to total $12.0 billion in 2023, when payment will jump by an estimated 8.6%. Similarly, unprecedented demand will precipitate and keep profit elevated.
This industry manufactures over-the-counter (OTC) cough and cold treatments and suppressants. Products include systemic remedies, such as antihistamines and combination products, decongestants and medicated candies. The industry does not include companies that are primarily retailers, such as pharmacies or department stores.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares."
Companies in the Cough and Cold Medicine Manufacturing OTC industry have benefited from increasing consumers purchasing over-the-counter (OTC) medications to address ailments with at-home treatments. The COVID-19 pandemic has been the most prominent proponent for industry demand. In 2020 industry revenue increased as consumers stockpiled industry products to address symptoms and potential infection with the fear of a new COVID-19 variant. Overall, industry-wide revenue has been growing at a CAGR of 5.6% over the past five years and is expected to total $12.0 billion in 2023, when payment will jump by an estimated 8.6%. Similarly, unprecedented demand will precipitate and keep profit elevated.
This industry manufactures over-the-counter (OTC) cough and cold treatments and suppressants. Products include systemic remedies, such as antihistamines and combination products, decongestants and medicated candies. The industry does not include companies that are primarily retailers, such as pharmacies or department stores.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares."
Table of Contents
41 Pages
ABOUT THIS INDUSTRY
Industry Definition
Main Activities
Similar Industries
Additional Resources
INDUSTRY AT A GLANCE
INDUSTRY PERFORMANCE
Executive Summary
Key External Drivers
Current Performance
Industry Outlook
Industry Life Cycle
PRODUCTS & MARKETS
Supply Chain
Products & Services
Demand Determinants
Major Markets
International Trade
Business Locations
COMPETITIVE LANDSCAPE
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Basis of Competition
Barriers to Entry
Industry Globalization
MAJOR COMPANIES
OPERATING CONDITIONS
Capital Intensity
Technology & Systems
Revenue Volatility
Regulation & Policy
Industry Assistance
KEY STATISTICS
Industry Data
Annual Change
Key Ratios
JARGON & GLOSSARY
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
